# Sätila Holding

> Sätila Holding is a VC fund in Skerike backing Biopharma, Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Skerike, Sweden
- Total investments: 1
- Last investment: Jun 2010
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.satilaholding.se

Sätila Holding is a VC fund in Skerike focused on Biopharma and Health Care. On SÃ¤tila Holding, They are constantly looking for exciting new business ideas. They invest in start up, buy-out, expansion and reorganization. They go in as partners and their investments tend to be between 1 and 10 million.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Adenovir Pharma | Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, UmeÃ¥ University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europeâ€™s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of UmeÃ¥, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). | $787K |  | Jun 15, 2010 |  |

1 of 1 investments shown.

## Co-investors
- [Augmenta](https://shizune.co/investors/profile/augmenta) — VC Fund, 1 deal together
- [Länsförsäkringar](https://shizune.co/investors/profile/lnsfrskringar-skne) — VC Fund, 1 deal together
- [PULS](https://shizune.co/investors/profile/puls) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Sweden](https://shizune.co/investors/biotechnology-investors-sweden)
- [Biotech Investors in Sweden](https://shizune.co/investors/biotech-investors-sweden)
- [Biotechnology VC Funds in Sweden](https://shizune.co/investors/biotechnology-vc-funds-sweden)
- [Biotech VC Funds in Sweden](https://shizune.co/investors/biotech-vc-funds-sweden)

## FAQ

### What does Sätila Holding invest in?

Sätila Holding invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sätila Holding last invest?

The most recent investment recorded for Sätila Holding closed in Jun 2010. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
